These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19298218

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cyclooxygenase-2: a therapeutic target.
    Turini ME, DuBois RN.
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A.
    Orv Hetil; 2002 Jul 07; 143(27):1643-8. PubMed ID: 12180001
    [Abstract] [Full Text] [Related]

  • 27. [Can COX-2 selective inhibitor prevent NSAIDs-related GI toxicity?].
    Konishi H, Yoshikawa T.
    Nihon Rinsho; 2011 Jun 07; 69(6):1110-5. PubMed ID: 21688637
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system.
    Fosslien E.
    Ann Clin Lab Sci; 1998 Jun 07; 28(2):67-81. PubMed ID: 9558445
    [Abstract] [Full Text] [Related]

  • 32. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL.
    Best Pract Res Clin Gastroenterol; 2001 Oct 07; 15(5):691-703. PubMed ID: 11566035
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs.
    Fiorucci S, Santucci L.
    Inflamm Allergy Drug Targets; 2011 Apr 07; 10(2):133-40. PubMed ID: 21275896
    [Abstract] [Full Text] [Related]

  • 36. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M, Battocchia A, Bianchi Porro G.
    Dig Liver Dis; 2007 Jun 07; 39(6):589-96. PubMed ID: 17459794
    [Abstract] [Full Text] [Related]

  • 37. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    Scand J Rheumatol Suppl; 1999 Jun 07; 109():31-7. PubMed ID: 10422544
    [Abstract] [Full Text] [Related]

  • 38. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG.
    Z Gastroenterol; 1999 Jan 07; 37(1):45-58. PubMed ID: 10091284
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.
    Borer JS, Simon LS.
    Arthritis Res Ther; 2005 Jan 07; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.